Addex Therapeutics (ADXN) Enterprise Value (2018 - 2026)
Addex Therapeutics (ADXN) posted Enterprise Value of -$1.2 million for Q1 2026, up 41.79% sequentially from -$2.1 million in Q4 2025, and up 62.0% YoY from -$739021.9 in Q1 2025.
Addex Therapeutics (ADXN) Enterprise Value (2018 - 2026) Analysis & Trends
Addex Therapeutics has reported Enterprise Value for 9 years, with the latest figure at -$1.2 million in Q1 2026.
- Quarterly Enterprise Value rose 62.0% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 million (up 62.0% YoY) and the FY2025 annual result came in at -$2.0 million, up 47.91% from the prior year.
- Enterprise Value climbed to -$1.2 million in Q1 2026 per ADXN's latest filing, from -$2.1 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$1.2 million in Q1 2026 and troughed at -$16.1 million in Q1 2022.
- A 5-year average of -$5.5 million and a median of -$4.2 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 69.15% in 2024, then plunged 68.67% in 2025.
- Over 5 years, Enterprise Value stood at -$7.2 million in 2022, then jumped by 39.67% to -$4.4 million in 2023, then gained by 12.31% to -$3.8 million in 2024, then soared by 46.19% to -$2.1 million in 2025, then jumped by 41.79% to -$1.2 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$1.2 million, -$2.1 million, and -$2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Addex Therapeutics | 515.38 Mn | 515.38 Mn | - | -1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.20 Mn |
| Dec 31, 2025 | -2.06 Mn |
| Sep 30, 2025 | -2.74 Mn |
| Jun 30, 2025 | -2.79 Mn |
| Mar 31, 2025 | -3.15 Mn |
| Dec 31, 2024 | -3.82 Mn |
| Sep 30, 2024 | -3.87 Mn |
| Jun 30, 2024 | -4.19 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Dec 31, 2023 | -4.36 Mn |
| Sep 30, 2023 | -5.38 Mn |
| Jun 30, 2023 | -7.99 Mn |
| Mar 31, 2023 | -6.05 Mn |
| Dec 31, 2022 | -7.22 Mn |
| Sep 30, 2022 | -10.80 Mn |
| Jun 30, 2022 | -9.15 Mn |
| Mar 31, 2022 | -16.13 Mn |
| Dec 31, 2021 | -22.23 Mn |
| Sep 30, 2021 | -16.90 Mn |
| Jun 30, 2021 | -19.90 Mn |